September 26 2024 - AbbVie's Parkinson's disease drug meets main goal in late-stage trial

AbbVie's Parkinson's disease drug meets main goal in late-stage trial
Arch raises another $3B biotech fund in pursuit of ‘coolest’ new science
Biogen cuts ties with Sage on failed tremor drug
AZ gets sought-after lung cancer approval for Tagrisso
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*